Clinical Sales Specialist (CS) - Naples, FL

Corcept Therapeutics

18 hours ago

2.7 on Glassdoor

Naples, Florida, United States

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Corcept's field-based sales professional will promote its portfolio of cortisol modulators to key healthcare providers within an assigned U.S. territory. The role operates within Corcept's compliance framework to advance product adoption and establish strong relationships with prescribers and hospital systems. This full-time position offers a pay range of $140,000 to $155,000 and requires a BA/BS and at least five years of sales experience, with endocrinology or specialty therapeutics background preferred.

Skills

Qualifications

BA/BS or Equivalent Work Experience

About Corcept Therapeutics

corcept.com

Corcept Therapeutics is a biopharmaceutical company that discovers and develops medicines that modulate the glucocorticoid receptor to treat disorders driven by excess cortisol. The company commercialized Korlym (mifepristone) for hyperglycemia secondary to endogenous Cushing’s syndrome and is advancing next‑generation, selective GR modulators (for example, relacorilant) through clinical development. Corcept combines translational science, clinical trials, and commercial capabilities to target endocrine and oncology indications where cortisol signaling contributes to disease. The company is headquartered in Menlo Park, California.

Recent company news

GlobeNewswire

CORCEPT THERAPEUTICS INCORPORATED (CORT) SHAREHOLDER ALERT

8 hours ago

Business Wire

REMINDER: Corcept Therapeutics Incorporated Investors With Significant Losses Must Act By April 21, 2026

1 day ago

TipRanks

Corcept Therapeutics Lawsuit: CORT Investors Face Losses After FDA Rejection and Alleged Misleading Statements

7 hours ago

Financial Times

CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm – Company Announcement - FT.com

12 hours ago

ChartMill

Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT

19 hours ago